0000899243-22-022561.txt : 20220615 0000899243-22-022561.hdr.sgml : 20220615 20220615161528 ACCESSION NUMBER: 0000899243-22-022561 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220613 FILED AS OF DATE: 20220615 DATE AS OF CHANGE: 20220615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spiegel Robert J. CENTRAL INDEX KEY: 0001492256 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39279 FILM NUMBER: 221017931 MAIL ADDRESS: STREET 1: C/O GERON CORPORATION STREET 2: 230 CONSTITUTION DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001797336 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823578375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: (857) 444-0553 MAIL ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-13 0 0001797336 Ayala Pharmaceuticals, Inc. AYLA 0001492256 Spiegel Robert J. OPPENHEIMER 4 REHOVOT L3 7670104 ISRAEL 1 0 0 0 Stock Option (Right to Buy) 1.63 2022-06-13 4 A 0 6250 0.00 A 2032-06-12 Common Stock 6250 6250 D This option vests and becomes exercisable on the earlier of (i) June 13, 2023 or (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. /s/ Roni Mamluk, Ph.D., Attorney-in-Fact for Robert J. Spiegel, M.D. 2022-06-15